VIM and colon carcinoma: CPMV were previously shown to bind to surface vimentin on cells [22] and these nanoparticles were capable of localizing to HT-29 tumors (a highly aggressive human colon carcinoma line) in vivo using the chick chorioallantoic membrane experimental human tumor xenograft tumor model [23].